title: [Effect of Electroacupuncture Intervention Combined with Gastrodin Administration on Neurological Function, Nogo-A and NgR Expression in the Frontal Lobe Cortex of Focal Cerebral Ischemia Rats].
abstract: OBJECTIVE
  To observe the effect of electroacupuncture (EA) intervention combined with medication (Gastrodin) on changes of neurological function and expression of Nogo-A and Nogo-A receptor (NgR) in the frontal lobe cortex around the ischemic loci of focal cerebral ischemia (FCI) rats, so as to explore its mechanism underlying improvement of neuroregeneration of FC.
  
  
  METHODS
  Fifty male Sprague-Dawley rats were randomly divided into normal control, model, EA, medication and EA+ medication groups (n = 10 in each group). The FCI model was induced by occlusion of the middle cerebral artery (MCAO) with thread embolus. EA was applied to the left "Quchi" (LI 11) and "Hegu" (Li 4) for 30 min, once daily for 14 days after MCAO. For rats of the medication group, Gastrodin (10 mg/kg) was administrated by intraperitoneal injection, once daily for 14 days. The neurological impairment was assessed by Zea Longa's scoring. The expression of Nogo-A and NgR in the frontal lobe cortex around the ischemic loci was detected by immunohistochemistry.
  
  
  RESULTS
  In comparison with the normal control group, cerebro- cortical Nogo-A and NgR expression levels of the model group vere significantly increased (P < 0.05). Compared with the model group, the Zea Longa's score and Nogo-A and NgR expression levels were evidently down-regulated in the EA, medication and EA + medication groups (P < 0.05). The Zea Longa's score and Nogo-A and NgR expression levels were significantly lower in the EA + medication group than in the EA and medication groups (P < 0.05).
  
  
  CONCLUSIONS
  EA intervention and Gastrodin administration can down-regulate cerebro-cortical Nogo-A and NgR protein expression in FCI rats, which may contribute to their action in improving neurological impairment. The effect of EA+ Gastrodin is better than simple EA or Gastrodin treatment.
authors.forename: Feng
authors.initials: F
authors.lastname: Wu
authors.forename: Huai-bin
authors.initials: HB
authors.lastname: Li
authors.forename: Jian
authors.initials: J
authors.lastname: Zhao
authors.forename: Hua-chun
authors.initials: HC
authors.lastname: Miao
authors.forename: Rui
authors.initials: R
authors.lastname: Huang
authors.forename: Jian
authors.initials: J
authors.lastname: Ding
authors.forename: Ke-ren
authors.initials: KR
authors.lastname: Xiong
mesh_terms: D000818:Animals; D001592:Benzyl Alcohols / Q000008:administration & dosage*; D002545:Brain Ischemia / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D003131:Combined Modality Therapy; D015671:Electroacupuncture; D005625:Frontal Lobe / Q000187:drug effects / Q000378:metabolism*; D058851:GPI-Linked Proteins / Q000235:genetics / Q000378:metabolism; D015870:Gene Expression; D005960:Glucosides / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D009185:Myelin Proteins / Q000235:genetics* / Q000378:metabolism*; D000070798:Nogo Proteins; D000070816:Nogo Receptor 1; D051381:Rats; D017207:Rats, Sprague-Dawley; D011956:Receptors, Cell Surface / Q000235:genetics / Q000378:metabolism*
chemical_list: D001592:Benzyl Alcohols; D058851:GPI-Linked Proteins; D005960:Glucosides; D009185:Myelin Proteins; D000070798:Nogo Proteins; D000070816:Nogo Receptor 1; C000603199:RTN4 protein, human; D011956:Receptors, Cell Surface; C000603197:Rtn4 protein, rat; C486581:Rtn4r protein, rat; C045345:gastrodin